SingulOmics Corporation was established in 2016 in New York as a genomic research and service company specializing in the emerging field of single-cell omics. Building on the unmatched expertise in single-cell genomics, transcriptomics, and epigenomics developed since the mid-2000s at Albert Einstein College of Medicine, our mission is to develop and provide high-quality, innovative single-cell services to research communities around the world. In addition, our end-to-end single-cell sequencing and analysis solutions enable global biopharmaceutical and diagnostic companies to accelerate target discovery and biomarker development.

We are proud to offer:


Check out SingulOmics in the News: